Abbott Laboratories

ABT · Health Care · Market cap $182B

Q1 FY26 Jan 1 – Mar 31, 2026 reported Jul 28, 2026

Revenue$11.2B +8% year over year

Gross profit$6.3B

Operating profit$1.3B

Net profit$1.1B 10% margin

Numbers and detail

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 31, 2026).
Item	Value	Share of revenue	Year over year
Revenue	11.2	100%	+8%
Medical Devices	5.9	53%
Diagnostic Products	3.1	28%
Nutritional Products	2.1	19%
Other	0.1	1%
Cost of revenue	−4.9	44%
Gross profit	6.3	56% margin	−1pp
Research & development	−0.8	7%	+0pp
SG&A	−3.7	34%	+4pp
Other	−0.4	4%	+0pp
Operating profit	1.3	12% margin	−4pp
Tax	−0.3
Net profit	1.1	10%	−3pp

All figures in billions of U.S. dollars, for Q4 FY25 (period ends Dec 31, 2025).
Item	Value	Share of revenue	Year over year
Revenue	11.5	100%	+4%
Medical Devices	5.7	50%	+12%
Diagnostic Products	2.5	22%	−2%
Nutritional Products	1.9	17%	−9%
Established Pharmaceutical…	1.4	12%	+9%
Cost of revenue	−4.9	43%
Gross profit	6.5	57% margin	+2pp
Research & development	−0.7	6%	+0pp
SG&A	−3.1	27%	+1pp
Other	−0.4	4%	+0pp
Operating profit	2.3	20% margin	+2pp
Tax	−0.6
Net profit	1.8	15%	−69pp

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Sep 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	11.4	100%	+7%
Medical Devices	5.4	47%	+15%
Diagnostic Products	2.3	20%	−7%
Nutritional Products	2.2	19%	+4%
Established Pharmaceutical…	1.5	13%	+7%
Cost of revenue	−5.1	45%
Gross profit	6.3	55% margin	+0pp
Research & development	−0.8	7%	+0pp
SG&A	−3	27%	+0pp
Other	−0.4	4%	+0pp
Operating profit	2.1	18% margin	+1pp
Tax	−0.6
Net profit	1.6	14%	−1pp

All figures in billions of U.S. dollars, for Q2 FY25 (period ends Jun 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	11.1	100%	+7%
Medical Devices	5.4	49%	+13%
Nutritional Products	2.2	20%	+3%
Diagnostic Products	2.2	20%	−1%
Established Pharmaceutical…	1.4	13%	+7%
Cost of revenue	−4.9	44%
Gross profit	6.3	56% margin	+1pp
Research & development	−0.7	7%	+0pp
SG&A	−3.1	28%	−1pp
Other	−0.4	4%	+0pp
Operating profit	2.1	18% margin	+2pp
Tax	−0.4
Net profit	1.8	16%	+3pp

Quarter by quarter

Pick a quarter and the diagram above changes. Bars compare revenue across the quarters we hold.

Quarter	Period	Reported	Revenue	Year over year	Operating margin	Net profit	Net margin
Q1 FY26	Jan 1 – Mar 31, 2026	Jul 28, 2026	$11.2B	+8%	12%	$1.1B	10%
Q4 FY25	Oct 1 – Dec 31, 2025	Feb 20, 2026	$11.5B	+4%	20%	$1.8B	15%
Q3 FY25	Jul 1 – Sep 30, 2025	Oct 29, 2025	$11.4B	+7%	18%	$1.6B	14%
Q2 FY25	Apr 1 – Jun 30, 2025	Jul 30, 2025	$11.1B	+7%	19%	$1.8B	16%